Bryan Claseman Email & Phone Number

Minneapolis, MN, US

Computational LIfe is developing a Digital Avatar to accelerate the Design and Development of Medical Solutions.

SMMG MedTech stands for Sales & Marketing Mastermind Group MedTech. The group was founded by Zeke Zielinski in 2013 in Minneapolis, Minnesota. It’s a “Think Tank” of MedTech Sales and Marketing background Executives in the Twin Cities. Members have Sales & Marketing leadership roles currently or in their past and is made of Director Level and above of.

Founded consulting firm to support entrepreneurs and early stage companies with formation, strategy, fund-raising and accelerated growth plans.

Rochester, Minnesota, US

Rochester, Minnesota, US

Initially appointed to an advisory position to support corporate governance, product development, and commercialization efforts; followed by election to Chair of Board of Governors.

Partnered with the founder as Executive Director to build a Board of Directors, Medical and Scientific Advisory Board, and Team of Professional Sports Athletes as business advisors - all specializing in concussions - before being appinted CEO. The team will support fund-raising efforts as well as provide product development and clinical insights to support.

Alexandria, VA, US

Working with entrepreneurial lead and technical lead on an NSF I-Corps project related to the rare disease of dystonia, with a focus on vocal and cervical applications.

The PLSA is a non-profit, 501c(3) organization. I develop the annual budget, process membership dues, pay organizations bills, and report financial results quarterly to the Board of Directors and semi-annually to the members.

Horsham, Pennsylvania, US

Recruited to strengthen medical device knowledge and experience on the board, assess management team, and enhance the strategic plan for growth and shareholder liquidity. With strong shareholder support, we successfully enhanced corporate governance, hired a new President and CEO and several key senior management team members, and in partnership with the.

Colorado Springs, Colorado, US

Lead marketing commercializing activities to support the anticipated launch of the Stellarex Drug Coated Balloon. Oversaw the design, development, and creation of the launch materials and developed sales training modules to prepare the organization for a successful launch. Managed the Key Opinion Leadership (KOL) program to enhance our communications with.

Wayne, Pennsylvania, US

• Intact Vascular is an early stage, venture backed, company focused on developing, clinically validating, and preparing for commercialization of a novel therapy for arterial dissection repair to improve clinical.
• Partnered with the CEO to create a new business plan and successfully raised $38.9 million Series B
• Created investor presentations with supporting market model and source references
• Updated the company’s brand and enhanced the value proposition and messaging
• Promoted the value of the technology and new therapy using clinical data at major conferences and publications
• Developed strong physician relationships to enhance and promote the technology and new therapy

Held Board Member, Treasurer, Secretary, Vice President, President, and Chairman positions over the 15 years with the organization.

• Preventice is an early stage company focused on commercializing a remote patient monitoring system that will reduce hospital re-admissions and improve the quality of patient care after discharge.Recruited by COO to.
• Rebuilt marketing department and developed a bottoms up budget
• Partnered with the COO to develop a 3-year Strategic Plan that provided an exit and return for the investors
• Supported the business collaboration effort to partner with eCardio Diagnostics (the third largest cardiac diagnostic company in the U.S.).

St. Paul, MN, US

• Cardiovascular Systems, Inc (CSI) is leading the fight against coronary and peripheral arterial calcified plaque – an under diagnosed and treated morphology that causes significant complications and increased.
• Rebuilt marketing department to 20 employees and managed a $12 million marketing budget
• Audited company brand and created new corporate brand, messaging, and value proposition
• Led the development and training of new marketing programs and sales tools to drive focus and accountability – resulting in consistent revenue growth over eight quarter (25+% annualized)
• Worked cross-functionally to align resources and programs on the new “calcium vision” and “message” to rapidly drive adoption of the new technology/therapy
• Created territory optimization plans and key metrics to enhance our sales structure and pricing models

Eden Prairie, MN, US

• SurModics, Inc. is a leading provider of surface modification and drug delivery technologies to the healthcare industry. A majority of their clients are interventional coronary, peripheral, and neuro-vascular.
• Completed strategic assessment of all business unit global markets and customer requirement, and prepared six business plans with financials to accelerate growth – including a low-particulate coating and a next.
• Worked cross-functionally to ensure alignment of resources to execute and implement the new strategies
• Developed and implemented a new brand that addressed the corporate and the three business unit needs
• Developed marketing communication plans to better target our broad customer audience
• Led development of a new integrated website (marketing, investor relations, and e-commerce)

Warsaw, Indiana, US

• Sulzer’s SpineTech worldwide spine division was acquired by Zimmer in 2005.Member of the executive management team that successfully conducted a turn-around of the business unit. Revenues which had been flat at $100.
• Managed the annual business unit Strategic Planning process
• Led due diligence teams, valuation, and negotiations on the acquisition of Abbott Spine in 2008, Endius in 2007, and the cervical plate from Encore Medical in 2007
• Negotiated and maintained distribution agreements with U&I Corporation (South Korea), Tutogen Medical, Regeneration Technologies, Spinal Elements, and Pioneer Surgical
• Negotiated over five license agreements to support internal development projects

• An early stage, venture backed, company focused on developing peripheral interventional vascular and non-vascular stents.Provided leadership of the product management and marketing communication teams and $1 million.
• Participated in a successful sale of IntraTherapeutics for $145 million to Sulzer Medica (l.k.a. Centerpulse)
• Grew product sales from less than $5 million to over $20 million in three years
• Led marketing efforts of the first femoral-popliteal approved stent product line (IntraCoil®), generating over $5 million of revenue the first year
• As Project Lead, achieved a successful, on-time launch of the 6-french Protégé™ self-expanding stent
• Project leader and marketing representative for the IntraGuard™ emboli protection development program

Marlborough, MA, US

• Boston Scientific acquired Schneider Worldwide in 1998. Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical.
• Found a partner with key intellectual property and secured a distribution agreement to allow the guide wire franchise to enter a new market segment, generating more than $10 million in new revenue the first year.
• Worked closely with the marketing and patent departments to evaluate over 225 business opportunities in twelve months, resulting in several licensing agreements.

• Pfizer acquired Schneider, American Medical Systems, and several other companies to create a medical device division in the early 1980’s.SCHNEIDER WORLDWIDE (1995-1998)Recruited by President to revive declining.
• Led strategic product portfolio planning for global interventional vascular business units resulting in double digit revenue growth
• Participated in U.S. product launch for the Wallstent® coronary stent, leveraging IDE clinical study data in additional to European sales experiences to drive more than $10 million in first year revenues
• Collaborated with the Director of Marketing to rebrand global coronary product portfolio with integration of U.S and European operations to leverage manufacturing cost and increase revenues and gross margins
• Participated in a new product innovation program at Pfizer to indentify, evaluate, and patent new products.AMERICAN MEDICAL SYSTEMS, INC. (1984-1995)Promoted to business development team to bring new technologies and.

Mba, Venture Management

Bs, Business Management

Cpim

A.S., Double Majored In Business Administration And Management Information Systems